TY  - JOUR
  - McKernan, DP; Fitzgerald, P; Dinan, TG; Cryan, JF
  - 2010
  - June
  - Neurogastroenterology and Motility
  - The probiotic Bifidobacterium infantis 35624 displays visceral antinociceptive effects in the rat.
  - Validated
  - Altmetric: 1 ()
  - Irritable bowel syndrome (IBS) is characterized by recurrent abdominal pain and altering bowel habit with a high percentage of patients displaying comorbid anxiety. Growing clinical and preclinical evidence suggests that probiotic agents may restore the altered brain-gut communication in IBS. In this study, we evaluated the efficacy of repeated treatment with three different probiotics in reducing visceral pain in visceral normosensitive (Sprague-Dawley [SD]) and visceral hypersensitive (Wistar-Kyoto [WKY]) rat strains.
  - 10.1111/j.1365-2982.2010.01520.x
DA  - 2010/06
ER  - 

@article{V38718209,
   = {McKernan, DP and  Fitzgerald, P and  Dinan, TG and  Cryan, JF},
   = {2010},
   = {June},
   = {Neurogastroenterology and Motility},
   = {The probiotic Bifidobacterium infantis 35624 displays visceral antinociceptive effects in the rat.},
   = {Validated},
   = {Altmetric: 1 ()},
   = {{Irritable bowel syndrome (IBS) is characterized by recurrent abdominal pain and altering bowel habit with a high percentage of patients displaying comorbid anxiety. Growing clinical and preclinical evidence suggests that probiotic agents may restore the altered brain-gut communication in IBS. In this study, we evaluated the efficacy of repeated treatment with three different probiotics in reducing visceral pain in visceral normosensitive (Sprague-Dawley [SD]) and visceral hypersensitive (Wistar-Kyoto [WKY]) rat strains.}},
   = {10.1111/j.1365-2982.2010.01520.x},
  source = {IRIS}
}